Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY008122-08
Application #
2162028
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1989-05-01
Project End
1999-04-30
Budget Start
1996-05-01
Budget End
1997-04-30
Support Year
8
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Schepens Eye Research Institute
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02114

  Publications

Gregory, Meredith S; Saff, Rebecca R; Marshak-Rothstein, Ann et al. (2007) Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligand. Cancer Res 67:11951-8
Gregory, Meredith S; Koh, Sean; Huang, Eric et al. (2005) A novel treatment for ocular tumors using membrane FasL vesicles to activate innate immunity and terminate immune privilege. Invest Ophthalmol Vis Sci 46:2495-502
Gregory, Meredith S; Repp, Amanda C; Holhbaum, Andreas M et al. (2002) Membrane Fas ligand activates innate immunity and terminates ocular immune privilege. J Immunol 169:2727-35